Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients

BACKGROUND: Kidney transplantation has improved survival and quality of life for patients with end-stage renal disease. Despite excellent short-term results due to better and more potent immunosuppressive drugs, long-term survival of transplanted kidneys has not improved accordingly in the last deca...

Full description

Saved in:

Bibliographic Details
Published in:	J Transl Med
Main Authors:	Reinders, Marlies EJ, Bank, Jonna R, Dreyer, Geertje J, Roelofs, Helene, Heidt, Sebastian, Roelen, Dave L, Huurman, Volkert AL, Lindeman, Jan, van Kooten, Cees, Claas, Frans HJ, Fibbe, Wim E, Rabelink, Ton J, de Fijter, Johan W
Format:	Artigo
Language:	Inglês
Published:	BioMed Central 2014
Subjects:	Protocol
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC4273432/ https://ncbi.nlm.nih.gov/pubmed/25491391 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-014-0331-x
Tags:	Add Tag No Tags, Be the first to tag this record!

Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients

Similar Items